Farallon Capital Management, L.L.C. 13D/13G Filings for PROGENICS PHARMACEUTICALS INC (PGNX)

Farallon Capital Management, L.L.C. 13D and 13G filings for PROGENICS PHARMACEUTICALS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-08
12:00 pm
Sale
2021-12-3113GPROGENICS PHARMACEUTICALS INC
PGNX
Farallon Capital Management, L.L.C.0
0.000%
-8,500,000decrease
(Position Closed)
Filing